Laman UtamaORNAV • HEL
add
Orion Oyj Class A
Tutup sebelumnya
€44.10
Julat hari
€44.00 - €45.35
Julat tahun
€32.50 - €49.85
Permodalan pasaran
6.37B EUR
Bilangan Purata
5.05K
Nisbah P/E
19.05
Hasil dividen
3.61%
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Hasil | 471.30J | 56.53% |
Perbelanjaan pengendalian | 117.40J | 28.73% |
Pendapatan bersih | 160.80J | 161.89% |
Margin untung bersih | 34.12 | 67.34% |
Pendapatan bagi setiap syer | 1.14 | 159.09% |
EBITDA | 215.00J | 129.70% |
Kadar cukai berkesan | 20.20% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 190.10J | 144.03% |
Jumlah aset | 1.61B | 17.17% |
Jumlah liabiliti | 683.30J | 28.51% |
Jumlah ekuiti | 924.40J | — |
Syer tertunggak | 140.50J | — |
Harga kepada buku | 6.70 | — |
Pulangan pada aset | 32.95% | — |
Pulangan pada modal | 45.77% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(EUR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 160.80J | 161.89% |
Tunai daripada operasi | 67.20J | 103.64% |
Tunai daripada pelaburan | -22.10J | 2.64% |
Tunai daripada pembiayaan | -7.60J | 10.59% |
Perubahan bersih dalam tunai | 37.60J | 1,039.39% |
Aliran tunai bebas | 67.88J | 1,674.51% |
Perihal
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
CEO
Diasaskan
1917
Tapak web
Pekerja
3,867